Navigation Links
Research Shows Improved Brain Performance With Citicoline
Date:6/25/2012

SALT LAKE CITY, June 25, 2012 /PRNewswire/ -- Healthy, middle-aged women taking supplements of citicoline, a naturally occurring brain health nutrient, saw improved attention, focus and recall, according to a peer-reviewed study conducted by University of Utah scientists. The study was published Wednesday in Food and Nutrition Sciences.

The double blind, placebo-controlled study composed of 60 healthy women between 40 and 60 years of age. After 28 days of citicoline administration, the study participants taking 250 mg indicated improved performance on cognitive function tests, and those taking 500 mg showed improvement and made significantly fewer errors on the tests compared to those in the placebo group.

"Our study findings indicate that citicoline supplementation was associated with improved attention focus and inhibition in a group of healthy female adult volunteers," says Dr. Deborah A. Yurgelun-Todd, Ph.D., professor of psychiatry at the U of U School of Medicine and one of the study's authors. "Prior research has shown that citicoline administration improved attention in a variety of patient populations, including those with cognitive deficits associated with illness or injury, but this study included only healthy, middle-aged women."

The study participants were divided into three groups; those taking a 250 mg dose and a 500 mg dose of citicoline under the brand name Cognizin®, and those taking a placebo.

"To our knowledge, this study is the first to examine the effects of low doses of citicoline on cognitive performance in healthy female adults," the authors concluded. "Practical applications of this research include the possible use of citicoline supplementation to improve cognitive deficits associated with normal aging, stress, and psychiatric disorders."

To view the study in its entirety, click here. For more information about Cognizin, including a list of products and supplements that contain Cognizin citicoline, visit www.cognizin.com.

About Cognizin
Cognizin® is a branded form of citicoline, a natural substance found in every cell of the body and especially vital to brain health. Cognizin is a highly stable, GRAS, ultra-pure and allergen free ingredient that is backed by science supporting its claims of improved attention, focus and recall.* *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

About Kyowa Hakko USA
Kyowa Hakko is an international health ingredients manufacturer and world leader in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products. Kyowa is the maker of branded ingredients including Cognizin® Citicoline, Lumistor® L-Hydroxyproline, Setria® Glutathione, Pantesin® Pantethine, as well as Sustamine(TM) L-Alanyl-L-Glutamine. Kyowa offers, manufacturers, and formulates one of the industry's most extensive lines of more than 50 amino acids and branch-chain amino acids, as well as nucleic acids, bio-products and fine chemicals.

Media Contact:
Ryann Rasmussen, PR Counsel, Integrated Marketing Group
O: (801) 538-0777 ext. 107
C: (435) 327-1876
ryannr@imgbranding.com


'/>"/>
SOURCE Kyowa Hakko USA
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Van Andel Institute Researchers Find Potential Drug Target For Aggressive Form Of Lymphoma
2. New Research Reveals Some Natural Supplements Effective Against Prostate Cancer
3. ASCO Impact Report From Encuity Research Indicates Oncologists Are Likely to Shift Patient Treatment Plans
4. The Michael J. Fox Foundation Launches The $14 Million-Edmond J. Safra Core Programs for PD Research
5. Prairie Education & Research Cooperative Joins MedNet Solutions iMedNet CRO Partner Program
6. Heptares and UK Medical Research Council Extend GPCR Collaboration
7. Thomson Reuters Finds Increase in New Research for Neglected Tropical Diseases
8. The UCB-Harvard Research Alliance Expands and Moves Forward
9. Asthma and COPD Drug Market Expected to Reach USD 26,965.5 Million Globally in 2017: Transparency Market Research
10. ResearchMoz: Global Power Wheelchairs Market Will Reach $3.9 Billion by 2018 - Market Research Report
11. Governor Gregoire and Congressman McDermott Join Novo Nordisk at Opening Event for Type 1 Diabetes Research Center in Seattle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... NEW YORK , April 28, 2016 ... of online consumer insights on healthcare, announced today that ... in their report Cool Vendor in Life Sciences, ... , April 15, 2016.  The report focuses on life-science- ... to gain insight from patients and doctors, confirm medication ...
(Date:4/28/2016)... Oramed Pharmaceuticals Inc. (NASDAQ: ... on the development of oral drug delivery systems, announced today ... conference, presented by Joseph Gunnar & Co. LLC, ... York . Nadav Kidron , CEO of Oramed, ... Presentation Details:   PIONEERS 2016, presented by ...
(Date:4/28/2016)... TapImmune,Inc. (TPIV), a clinical-stage immune-oncology company ... and vaccines for the treatment of cancer & metastatic disease, ... Growth Capital Expo to be held on May 3 ... in Las Vegas, Nevada.  The Company presentation will be ... by Dr. John N. Bonfiglio a TapImmune Board ...
Breaking Medicine Technology:
(Date:4/28/2016)... ... ... ProText Layouts is a set of 30 self-animating kinetic text layouts created ... video editors can create an energetic typography video with incredible ease. Utilize intuitive ... text-based videos have never been easier. , ProText Layouts includes 30 kinetic text layouts ...
(Date:4/28/2016)... ... April 28, 2016 , ... University of New England President Danielle N. ... vice president of Student Engagement. In addition to his role as director of ... areas. , “In the space of just one year Jack has distinguished himself ...
(Date:4/28/2016)... D.C., (PRWEB) , ... April 28, 2016 , ... ... systems, and the Campaign for Tobacco-Free Kids, a leading force in the fight ... promote federal, state and local policies that can help reduce tobacco use. The ...
(Date:4/28/2016)... ... 2016 , ... Horizon Blue Cross Blue Shield of New ... make transformative changes in how health care is delivered and financed in New ... breakthroughs in cellular medicine to treat disease. After accepting an invitation to speak ...
(Date:4/28/2016)... ... April 28, 2016 , ... Amada Senior Care, premier provider of ... San Antonio – its San Antonio West location. Prior to entering the senior care ... The grand opening of Amada San Antonio West will take place on Friday, April ...
Breaking Medicine News(10 mins):